{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:31:03Z","timestamp":1778859063481,"version":"3.51.4"},"reference-count":31,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Bia\u0142ystok","award":["B.SUB.24.400"],"award-info":[{"award-number":["B.SUB.24.400"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Although dysregulated sphingolipid metabolism was observed in many malignant tumors, bladder cancer has not yet been examined in this regard. This study aims to investigate the metabolism of bioactive sphingolipids across different stages of urothelial urinary bladder cancer (UBC). Forty-eight patients with UBC were included in this study. The neoplasms were classified as either non-muscle-invasive (NMIBC, n = 24) or muscle-invasive (MIBC, n = 24). Samples of the healthy bladder tissue were taken from the patients who underwent radical cystectomy. The content of sphingolipids was measured using an HPLC method, and the mRNA expression of sphingolipid transporters and metabolizing enzymes was evaluated using RT-PCR. Compared to the healthy bladder tissue, the UBC, regardless of the stage, showed an elevated expression of SphK1, Spns2, and ABCC1. The changes in the level of bioactive sphingolipids were strongly stage-dependent. MIBC showed accumulation of sphingosine-1-phosphate (S1P) and ceramide, whereas the content of these sphingolipids in the NMIBC tumor was not different from that of healthy tissue. Moreover, MIBC, compared to NMIBC, was characterized by higher levels of sphingosine and dihydroceramide. We conclude that profound alterations in sphingolipid metabolism develop upon UBC transition from non-muscle-invasive to muscle-invasive. They include the accumulation of S1P, resulting from the increased availability of sphingosine generated from ceramide, which also builds up due to a further activation of its de novo synthesis. We hypothesize that the dysregulation of S1P metabolism leading to the accumulation of this tumor-promoting sphingolipid contributes to the progression of UBC.<\/jats:p>","DOI":"10.3390\/ijms252211889","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T11:36:39Z","timestamp":1730806599000},"page":"11889","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Urothelial Urinary Bladder Cancer Is Characterized by Stage-Dependent Aberrations in Metabolism of Bioactive Sphingolipids"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1453-8501","authenticated-orcid":false,"given":"Grzegorz","family":"M\u0142ynarczyk","sequence":"first","affiliation":[{"name":"Department of Urology, Medical University of Bia\u0142ystok, Sk\u0142odowskiej-Curie 24A, 15-276 Bia\u0142ystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4936-3120","authenticated-orcid":false,"given":"Agnieszka","family":"Mik\u0142osz","sequence":"additional","affiliation":[{"name":"Department of Physiology, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bia\u0142ystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7407-8156","authenticated-orcid":false,"given":"Adrian","family":"Chabowski","sequence":"additional","affiliation":[{"name":"Department of Physiology, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bia\u0142ystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Baranowski","sequence":"additional","affiliation":[{"name":"Department of Physiology, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bia\u0142ystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/PL00000836","article-title":"Sphingolipids in mammalian cell signalling","volume":"58","author":"Ohanian","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.chemphyslip.2015.07.007","article-title":"Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase)","volume":"197","author":"Sanllehi","year":"2016","journal-title":"Chem. Phys. Lipids."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/pr.107.07113","article-title":"\u201cInside-out\u201d signaling of sphingosine-1-phosphate: Therapeutic targets","volume":"60","author":"Takabe","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acr.2018.04.007","article-title":"Mechanisms of Ceramide-Dependent Cancer Cell Death","volume":"140","author":"Nganga","year":"2018","journal-title":"Adv. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12935-019-1014-8","article-title":"Roles of sphingosine-1-phosphate signaling in cancer","volume":"19","author":"Wang","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11427-017-9046-6","article-title":"Targeting sphingosine-1-phosphate signaling for cancer therapy","volume":"60","author":"Xie","year":"2017","journal-title":"Sci. China Life Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21873\/anticanres.13078","article-title":"Bioactive Sphingolipids as Biomarkers Predictive of Disease Severity and Treatment Response in Cancer: Current Status and Translational Challenges","volume":"39","author":"Sedic","year":"2019","journal-title":"Anticancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.prostaglandins.2010.03.002","article-title":"Altered sphingolipid metabolism in human endometrial cancer","volume":"92","author":"Knapp","year":"2010","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/jcb.30227","article-title":"Grade-dependent changes in sphingolipid metabolism in clear cell renal cell carcinoma","volume":"123","author":"Mlynarczyk","year":"2022","journal-title":"J. Cell. Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3892\/ijmm.2021.5037","article-title":"SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO\/STAT3 axis","volume":"48","author":"Qin","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s13277-013-1275-0","article-title":"Increased SPHK1 expression is associated with poor prognosis in bladder cancer","volume":"35","author":"Meng","year":"2014","journal-title":"Tumour Biol."},{"key":"ref_15","first-page":"763","article-title":"Sphingosine Kinase 1 Acts as a Hypoxia-Upregulated Oncogene to Regulate Cell Invasion and Resistance to NK Cell Killing in Bladder Carcinoma Cells","volume":"52","author":"Li","year":"2022","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wollny, T., Wnorowska, U., Piktel, E., Suprewicz, L., Krol, G., Gluszek, K., Gozdz, S., Kopczynski, J., and Bucki, R. (2022). Sphingosine-1-Phosphate-Triggered Expression of Cathelicidin LL-37 Promotes the Growth of Human Bladder Cancer Cells. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137443"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s13577-020-00470-3","article-title":"LncRNA MAFG-AS1 regulates miR-125b-5p\/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells","volume":"34","author":"Tang","year":"2021","journal-title":"Hum. Cell."},{"key":"ref_18","first-page":"1213","article-title":"miR-613 inhibits bladder cancer proliferation and migration through targeting SphK1","volume":"9","author":"Yu","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/1440-1681.13124","article-title":"SPNS2 promotes the malignancy of colorectal cancer cells via regulating Akt and ERK pathway","volume":"46","author":"Gu","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"109821","DOI":"10.1016\/j.cellsig.2020.109821","article-title":"Spinster homolog 2 in cancers, its functions and mechanisms","volume":"77","author":"Fang","year":"2021","journal-title":"Cell. Signal."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chen, C.L., Meng, E., Wu, S.T., Lai, H.F., Lu, Y.S., Yang, M.H., Tsao, C.W., Kao, C.C., and Chiu, Y.L. (2021). Targeting S1PR1 May Result in Enhanced Migration of Cancer Cells in Bladder Carcinoma. Cancers, 13.","DOI":"10.3390\/cancers13174474"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s12094-019-02049-3","article-title":"Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma","volume":"21","author":"Palangi","year":"2019","journal-title":"Clin. Transl. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.ejca.2015.07.021","article-title":"Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target","volume":"51","author":"Go","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41419-018-1298-y","article-title":"Sphingosine 1 phosphate receptor-1 (S1P1) promotes tumor-associated regulatory T cell expansion: Leading to poor survival in bladder cancer","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Bettiga, A., Aureli, M., Colciago, G., Murdica, V., Moschini, M., Luciano, R., Canals, D., Hannun, Y., Hedlund, P., and Lavorgna, G. (2017). Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism. Sci. Rep., 7.","DOI":"10.1038\/srep42157"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.11024","article-title":"Elevation of de novo ceramide synthesis in tumor masses and the role of microsomal dihydroceramide synthase","volume":"105","author":"Koyanagi","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/002215540305100603","article-title":"Enhanced serine palmitoyltransferase expression in proliferating fibroblasts, transformed cell lines, and human tumors","volume":"51","author":"Carton","year":"2003","journal-title":"J. Histochem. Cytochem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.prostaglandins.2013.10.001","article-title":"Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute myocardial infarction","volume":"106","author":"Knapp","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_30","first-page":"6001","article-title":"Selection of reference genes for gene expression studies in human bladder cancer using SYBR-Green quantitative polymerase chain reaction","volume":"14","author":"Zhang","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/11889\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:26:48Z","timestamp":1760113608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/11889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":31,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ijms252211889"],"URL":"https:\/\/doi.org\/10.3390\/ijms252211889","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]}}}